We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Warning Wire: Bevy Of Big-Name Cos. Targeted

Law360 (March 6, 2018, 6:11 PM EST) -- The U.S. Food and Drug Administration's latest disciplinary moves targeted a quartet of household names in the drug and device industries, and one of the moves marked the first discipline by an obscure FDA office in three years. Here's a look at the latest rebukes.

CSL Behring Scolded for Hemophilia Promo

Perhaps the most notable action targeted biotech company CSL Behring LLC over promotional efforts for hemophilia treatment Idelvion. The company received a so-called untitled letter from the advertising office in the FDA's Center for Biologics...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.